BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Peng XM, Peng WW, Yao JL. Codon 249 mutations of p53 gene in development of hepatocellular carcinoma. World J Gastroenterol 1998; 4(2): 125-127 [PMID: 11819254 DOI: 10.3748/wjg.v4.i2.125]
URL: https://www.wjgnet.com/1007-9327/full/v4/i2/125.htm
Number Citing Articles
1
Miao-Wang Hao, Ying-Rui Liang, Yan-Fang Liu, Li Liu, Ming-Yao Wu, Huan-Xing Yang. Transcription factor EGR-1 inhibits growth of hepatocellular carcinoma and esophageal carcinoma cell lines. World Journal of Gastroenterology 2002; 8(2): 203-207 doi: 10.3748/wjg.v8.i2.203
2
Jiangbo Liu, Wei Li, Miao Deng, Dechun Liu, Qingyong Ma, Xiaoshan Feng, William B. Coleman. Immunohistochemical Determination of p53 Protein Overexpression for Predicting p53 Gene Mutations in Hepatocellular Carcinoma: A Meta-Analysis. PLOS ONE 2016; 11(7) doi: 10.1371/journal.pone.0159636
3
Mechanisms and Therapy of Liver Cancer. Advances in Cancer Research 2021; 149 doi: 10.1016/bs.acr.2020.10.001
4
5
Yi-Long Xue, Shi-Feng Zhao, Yun-Luo, Xin-Jian Li, Zhong-Ping Duan, Xiao-Ping Chen, Wen-Ge Li, Xiao-Qiang Huang, Yan-Ling Li, Xin-Cui, Da-Guang Zhong, Zuo-Yun Zhang, Zhi-Qiang Huang. TECA hybrid artificial liver support system in treatment of acute liver failure. World Journal of Gastroenterology 2001; 7(6): 826-829 doi: 10.3748/wjg.v7.i6.826
6
Li Hua Liu, Wen Hua Xiao, Wei Wen Liu. Effect of 5-2Aza-2'-deoxycytidine on the P16 tumor suppressor gene in hepatocellular carcinoma cell line HepG2. World Journal of Gastroenterology 2001; 7(1): 131-135 doi: 10.3748/wjg.v7.i1.131
7
Man-Ran Liu, Kai-Feng Pan, Zhen-Fu Li, Yi Wang, Da-Jun Deng, Lian Zhang, You-Yong Lu. Rapid screening mitochondrial DNA mutation by using denaturing high-performance liquid chromatography. World Journal of Gastroenterology 2002; 8(3): 426-430 doi: 10.3748/wjg.v8.i3.426
8
Fernanda Magri de Carvalho, Thiago de Almeida Pereira, Patrícia Lofego Gonçalves, Robson Dettmann Jarske, Fausto Edmundo Lima Pereira, Iuri Drumond Louro. Hepatocellular carcinoma and liver cirrhosis TP53 mutation analysis reflects a moderate dietary exposure to aflatoxins in Espírito Santo State, Brazil. Molecular Biology Reports 2013; 40(8) doi: 10.1007/s11033-013-2587-2
9
Mohamed A. Hameed, Owayes M. Hamed. Detection of P53 suppressor gene mutation in women with breast cancer in Mosul city. 2ND INTERNATIONAL CONFERENCE OF MATHEMATICS, APPLIED SCIENCES, INFORMATION AND COMMUNICATION TECHNOLOGY 2023; 2834 doi: 10.1063/5.0161448
10
Wan-Sheng Ji, Jia-Lu Hu, Jun-Wen Qiu, Bo-Rong Pan, Dao-Rong Peng, Bing-Long Shi, Shao-Juan Zhou, Kai-Chun Wu, Dai-Ming Fan. Relationship between genotype and phenotype of flagellin C in Salmonella. World Journal of Gastroenterology 2001; 7(6): 864-867 doi: 10.3748/wjg.v7.i6.864
11
Hale Kirimlioglu, Anthony J. Demetris, Michael A. Nalesnik. Hepatocellular Cancer. Current Clinical Oncology 2005;  doi: 10.1007/978-1-59259-844-1_4
12
Michael A. Nalesnik, Tong Wu, Eizaburo Sasatomi, Anthony J. Demetris. Hepatocellular Carcinoma. 2009;  doi: 10.1007/978-1-60327-376-3_6
13
Shuang-Ping Guo, Wen-Liang Wang, Yu-Qiang Zhai, Yi-Ling Zhao. Expression of nuclear factor-κB in hepatocellular carcinoma and its relation with the X protein of hepatitis B virus. World Journal of Gastroenterology 2001; 7(3): 340-344 doi: 10.3748/wjg.v7.i3.340
14
Jun Cui, Dong Hua Yang, Xiang Jun Bi, Zi Rong Fan. Methylation status of c-fms oncogene in HCC and its relationship with clinical pathology. World Journal of Gastroenterology 2001; 7(1): 136-139 doi: 10.3748/wjg.v7.i1.136
15
Zhen-Hua Xu, Mu-Jun Zhao, Tsai-Ping Li. p73β inhibits transcriptional activities of enhancer I and X promoter in hepatitis B virus more efficiently than p73α. World Journal of Gastroenterology 2002; 8(6): 1094-1097 doi: 10.3748/wjg.v8.i6.1094
16
Li-Wu Lin, Xue-Ying Lin, Yi-Mi He, Shang-Da Gao, Xiao-Dong Lin. Biological characteristics of HCC by ultrasound-guided aspiration biopsy and its clinical application. World Journal of Gastroenterology 2003; 9(5): 941-945 doi: 10.3748/wjg.v9.i5.941
17
Ming Shi, Fu-Sheng Wang, Zu-Ze Wu. Synergetic anticancer effect of combined quercetin and recombinant adenoviral vector expressing human wild-type p53, GM-CSF and B7-1 genes on hepatocellular carcinoma cells <i>in vitro</i>. World Journal of Gastroenterology 2003; 9(1): 73-78 doi: 10.3748/wjg.v9.i1.73
18
Ming Kei Lee, Kanaga Sabapathy. The R246S hot-spot p53 mutant exerts dominant-negative effects in embryonic stem cells in vitro and in vivo. Journal of Cell Science 2008; 121(11) doi: 10.1242/jcs.022822
19
Chong Lu, Hui-Mian Xu, Qun Ren, Yang Ao, Zhen-Ning Wang, Xue Ao, Li Jiang, Yang Luo, Xue Zhang. Somatic mutation analysis of p53 and ST7 tumor suppressor genes in gastric carcinoma by DHPLC. World Journal of Gastroenterology 2003; 9(12): 2662-2665 doi: 10.3748/wjg.v9.i12.2662
20
K. Pandima Devi, B. Sivamaruthi, PV Kiruthiga, S. Karutha Pandian. Study of p53 codon 72 polymorphism and codon 249 mutations in Southern India in relation to age, alcohol drinking and smoking habits. Human & Experimental Toxicology 2010; 29(6) doi: 10.1177/0960327109354938
21
Xiao-Mou Peng, Xue-Juan Chen, Jian-Guo Li, Lin Gu, Yang-Su Huang, Zhi-Liang Gao. Novel assay of competitively differentiated polymerase chain reaction for screening point mutation of hepatitis B virus. World Journal of Gastroenterology 2003; 9(8): 1743-1746 doi: 10.3748/wjg.v9.i8.1743
22
Yan Luo, Li-Juan Wang, Cheng-Long Wang. Mechanistic interplay between aflatoxin B1 and tissue inhibitor of metalloproteinase-3 in hepatocellular carcinoma. World Journal of Hepatology 2025; 17(10): 109391 doi: 10.4254/wjh.v17.i10.109391
23